- Coordinator
- Gottfried Wilhelm Leibniz Universitaet Hannover, Germany
- Runs
- 1 June 2026 to 30 November 2027
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 2 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101293293
What the project is doing
In the project's own words, from its summary on CORDIS.
Endometriosis and adenomyosis affect over 190 million women worldwide and remain underdiagnosed for an average of eight years, despite being linked to debilitating pain, infertility and impaired quality of life. Infertility itself affects one in six couples in the EU, often requiring assisted reproductive technologies such as in-vitro fertilization (IVF). Mounting evidence connects both disorders, as well as IVF implantation failure, to abnormal uterine peristalsis—the wave-like contractions of the uterus that guide sperm transport, facilitate implantation, and enable menstrual shedding.
Yet, despite its central role, no method exists to reliably and non-invasively measure uterine peristalsis in clinical or research settings. Building on the ERC Starting Grant EARTHWORM, which pioneers artificial AI-driven Magnetic Resonance Imaging (MRI), SyncWorm will significantly increase its impact: a wearable, MRI-compatible belt to characterize uterine peristalsis. By combining the high temporal resolution of electrophysiology with the spatial mapping of dynamic MRI, SyncWorm will deliver validated, quantitative, reproducible measures of uterine peristalsis.
This diagnostic innovation has transformative potential: to guide IVF timing and improve implantation success, to stratify treatment in endometriosis and adenomyosis and to advance research into uterine physiology. The project will develop and validate a safe, robust MRI-compatible belt with optimized electrode placement; demonstrate discriminatory power in targeted patient studies; and assess user acceptability and market potential with an industrial partner.
SyncWorm addresses a clear unmet clinical need with high-risk/high-gain potential: enabling the first non-invasive, spatio-temporal assessment of uterine peristalsis. If successful, this innovation will unlock a new diagnostic paradigm in women’s health, accelerate translational research, and open a market across infertility, gynecology, and beyond.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Gottfried Wilhelm Leibniz Universitaet Hannover | Hannover | Germany | Coordinator |
| Medizinische Hochschule Hannover | Hannover | Germany | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI